Nanjing Immunophage Biotech Co., Ltd clinical trial pipeline
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-14
What changed in the last 30 days
1 trial changed in the last 30 days: 0 stopped, 1 with a notable change, 0 with minor changes only.
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates
New trial filings, last 30 days
| First posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-11-13 | NCT07935291 Study of IPG1094 Tablets in Chinese Healthy Adults and Obese Adults | Phase 1 | Not Yet Recruiting |
Active trials by phase
| Phase 1 | 2 | |
| Phase 1/2 | 2 | |
| Phase 2 | 1 |
Disease areas by active trials
Obesity (1) · Ulcerative Colitis (1)
Get alerts when Nanjing Immunophage Biotech Co., Ltd's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.